Alzheimer's Disease is "predictable" | Blood screening helps early diagnosis and treatment | "Anti-amyloid drugs" delay the deterioration of the disease from the source | Canossa Hospital provides a subsidized screening program and provides one-stop diagnosis and treatment services   As individuals age, the risk of developing dementia increases, with Alzheimer’s disease being the most common manifestation. The progression of this condition can result in significant challenges and serious implications for affected individuals and their families. Recently, there have been significant advancements in both screening and treatment, allowing for earlier detection and intervention. Canossa Hospital has unveiled an innovative blood test technology capable of identifying individuals at risk for Alzheimer's disease even before symptoms emerge, marking a significant step forward in early diagnosis and care. Additionally, the hospital has implemented a subsidized screening initiative, which features a discounted revolutionary blood test and a complimentary "Montreal Cognitive Assessment," aimed at offering comprehensive medical services from diagnosis to treatment.   Subsidized screening programme details    Chinese news links: am730: 阿茲海默症  早期治療延緩退化 東方日報: 阿茲海默症易錯過治療機會　及早篩查治療有助維持認知能力 星島日報: 新型血液檢查 及早發現早期阿茲海默症患者 經濟日報: 阿茲海默症可及早發現　新型血液檢測偵查高危人士 HK01: 60歲男患輕度認知障礙 接受抗類澱粉蛋白藥物 如常工作旅行 U港生活: 血液檢測新突破：及早發現阿茲海默症，抗類澱粉蛋白藥物延緩腦退化

  Canossa Hospital (Caritas) and KA Imaging have officially signed a Memorandum of Understanding (MOU) during the Asia Summit on Global Health 2025, marking a significant partnership aimed at advancing healthcare technologies.   This collaboration signifies the launch of the world’s first portable dual-energy Reveal™ 35C X-ray detector in Hong Kong.  This detector was developed by KA Imaging, a spin-off from the University of Waterloo in Canada known for its innovative X-ray imaging technologies.   The Reveal 35C X-ray detector is a single-exposure, dual-energy, flat-panel x-ray detector, using a combination of multiple scintillation layers. With just one radiographic exposure, it can acquire three images, a traditional Digital Radiographic image, a soft tissue image and a bone image. This innovation has the potential to improve patient outcomes by enhancing pneumonia detection, improving lesion visibility,  providing clear line/tube placement verification and more, all without motion artifacts or extra radiation exposure. The unique benefits of the portable detector can also reduce patient’s discomfort and the risks associated with transportation.    By working together, Canossa Hospital and KA Imaging aim to enhance patient care and hospital services through the implementation of cutting-edge innovations.

Confirms We Have Not Used the Affected Brand of Medical Light At Canossa Hospital (Caritas) , patient safety is our top priority. We have comprehensively reviewed this matter and confirm that our hospital has not used the "Draeger - Polaris 50." Consequently, we are not affected by any safety issues related to this specific equipment.